Moderna (NASDAQ:MRNA) shares moved higher on Thursday, building on the previous session’s strong gains as investors focused ...

Vaccination against seasonal respiratory viruses requires patients to receive a shot for each pathogen. Moderna is a step closer to offering a combination vaccine that protects against both influenza ...

The speed of vaccine development is a stunning scientific success, although there is some hesitancy among the public Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency ...

Moderna, the biotech company behind one of the original mRNA COVID-19 vaccines, is undergoing an AI-powered workplace transformation. In partnership with OpenAI, Moderna has created thousands of ...

Moderna has interim data it says support advancing its avian influenza vaccine into a late-stage clinical trial, but the U.S. government has canceled the federal contract that would have financed it, ...